PMID: 8948250Oct 1, 1996Paper

Operations, total hospital stay and costs of critical leg ischemia. A population-based longitudinal outcome study of 321 patients

Acta Orthopaedica Scandinavica
M EnerothB M Persson

Abstract

In a longitudinal analysis of all 321 patients in a defined population having surgery for critical leg ischemia during 1 year in Malmöhus county (0.53 million inhabitants), Sweden, we investigated all vascular procedures and amputations on both legs, total hospital stay and hospital costs from the first procedure in each patient until death or at follow-up at least 6 years postoperatively. The first (key) operation during the inclusion year was a reconstructive vascular procedure in 96 patients, a restorative vascular procedure in 111 and a major amputation in 114 patients. One third of those with a reconstructive and half of those with a restorative key procedure had an ipsilateral major amputation. The mean number of surgical procedures and length of hospital stay among all patients were 3 (1-19) procedures and 117 (1-1097) days, respectively. Of the total number of days in hospital, less than half were in surgical departments, 10% in other acute-care departments and almost half in rehabilitation clinics and nursing homes. The total hospital and surgical costs among all patients were USD 15.1 million (mean USD 47,000/patient), with no significant differences in relation to the key operation. We conclude that patients who have...Continue Reading

References

Jan 1, 1992·International Orthopaedics·M Eneroth, B M Persson
Jul 1, 1991·Circulation·V Ralevic, G Burnstock
Feb 1, 1991·Acta Orthopaedica Scandinavica·L BorgquistK G Thorngren
Jan 16, 1986·The New England Journal of Medicine·R S RhodesP K Jones
Apr 1, 1988·Archives of Surgery·C A RaviolaW S Moore
Jun 1, 1988·European Journal of Vascular Surgery·S K GuptaM L Gliedman
Aug 1, 1995·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·R M GreenJ A DeWeese
Feb 1, 1995·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J S BuddP R Bell
Feb 1, 1995·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·B F JohnsonJ D Beard
Jul 1, 1995·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
Jul 1, 1994·Journal of Vascular Surgery·P G KalmanT F Lindsay
Oct 1, 1993·The British Journal of Surgery·R D SayersP R Bell
Jan 1, 1994·European Journal of Vascular Surgery·A E PedersenP Holstein
Feb 1, 1993·Annals of Internal Medicine·M C Creditor
Sep 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·J LarssonA Stenström

❮ Previous
Next ❯

Citations

Apr 27, 2013·Circulation Research·Zankhana Raval, Douglas W Losordo
Apr 28, 2012·Physical Medicine and Rehabilitation Clinics of North America·Gail LatliefM Jason Highsmith
Sep 29, 2011·Journal of the American College of Surgeons·Neal R BarshesUNKNOWN MOVIE Study Collaborators
Mar 26, 2003·The British Journal of Dermatology·J R MekkesJ D Bos
Oct 6, 2011·Journal of Vascular Surgery·James P MoriartyUNKNOWN Society for Vascular Surgery Committee on Comparative Effectiveness
Oct 8, 1999·Journal of Vascular Surgery·P ShackleyJ Michaels
May 11, 2001·Archives of Physical Medicine and Rehabilitation·D D CardenasS M Gnatz
Oct 30, 2003·Journal of Rehabilitation Research and Development·Douglas G SmithJoseph M Czerniecki
Mar 23, 2019·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Rianne J VossenRon Balm
Jun 13, 2003·Family & Community Health·Daniel I GalperDaniel J Cox
Feb 1, 2005·Foot & Ankle International·William E SaarGregory C Berlet
May 15, 2018·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Linda TangRamon L Varcoe
Jun 3, 2004·Prosthetics and Orthotics International·A JohannessonT Oberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.